Loading
₹5,350.50
+58.50+1.11%today
Market closed · 7 Oct, 3:30 pm
−2.58%over 1 year
Today's range
₹5,292.00₹5,404.50
52-week range
₹5,051.00₹5,933.50
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 14,532 | 2,302 | 15.8% | 192.51 |
| FY25 | 12,805 | 2,165 | 16.9% | 181.11 |
| FY24 | 12,439 | 1,796 | 14.4% | 150.19 |
| FY23 | 11,440 | 984 | 8.6% | 82.31 |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 49.70% | 51.20% | 51.20% | 51.20% |
| FIIs | 10.42% | 10.16% | 9.97% | 9.48% |
| DIIs | 22.63% | 21.40% | 21.54% | 21.93% |
| of which mutual funds | 16.71% | 15.57% | 16.06% | 16.94% |
| Government | n/a | 0.00% | n/a | 0.00% |
| Public | 17.25% | 17.25% | 17.30% | 17.40% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Glenmark Pharmaceuticals Ltd.GLENMARK | 2,282.30 | −1.24% | 64,412 |
| Alkem Laboratories Ltd.ALKEM · this stock | 5,350.50 | +1.11% | 63,973 |
| Aster DM Quality Care Ltd.ASTERDM | 680.10 | −0.67% | 59,282 |
| Fortis Healthcare Ltd.FORTIS | 779.10 | +1.98% | 58,819 |
| Biocon Ltd.BIOCON | 360.00 | −2.47% | 58,669 |
| Abbott India Ltd.ABBOTINDIA | 26,100.00 | −0.06% | 55,461 |
| Gland Pharma Ltd.GLAND | 3,159.00 | +5.09% | 52,127 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.